NEW YORK, Aug. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Petco Health and Wellness Company, Inc. ("Petco" or the "Company") (NASDAQ: WOOF) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Petco investors who were adversely affected by alleged securities fraud between January 14, 2021 and June 5, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/petco-lawsuit-su ...

SAN DIEGO, Aug. 21, 2025 /PRNewswire/ -- Petco (Nasdaq: WOOF), today announced that the Company is scheduled to present at the 32nd Annual Goldman Sachs Global Retailing Conference on Thursday, Sept. 4, 2025, at approximately 1:50 p.m. Eastern Time. We're proud to be "where the pets go" to find everything they need to live their best lives for more than 60 years — from their favorite meals and toys, to trusted supplies and expert support from people who get it, because we live it. We believe in the universa ...

Core Viewpoint - A class action lawsuit has been filed against Petco Health and Wellness Company, Inc. for allegedly making materially false and misleading statements regarding its business operations and growth prospects during the pandemic [1][3]. Summary by Relevant Sections Lawsuit Details - The lawsuit was filed in the United States District Court for the Southern District of California on behalf of all individuals and entities who purchased Petco securities between January 14, 2021, and June 5, 2025 [1]. - Investors have until August 29, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit [1]. Allegations Against Petco - The lawsuit claims that Petco's pandemic-related growth was unsustainable and that its business model focused on premium pet food was overstated [3]. - It is alleged that the company downplayed the severity of operational issues and the necessary changes to address them, which could negatively impact comparable sales metrics [3]. - The defendants are accused of overstating Petco's ability to achieve sustainable and profitable growth [3].

Core Viewpoint - Pet Valu Holdings Ltd. has raised its 2025 financial outlook and announced a succession plan for its CEO, indicating strong business performance and strategic leadership transition [1][3][4]. Financial Performance - For Q2 2025, Pet Valu reported system-wide sales of $369.9 million, a 4.6% increase compared to Q2 2024, with same-store sales growth of 2.6% [7][11]. - Revenue reached $280.6 million, up 5.8% from $265.2 million in Q2 2024, driven by growth in franchise and retail sales [10]. - Adjusted EBITDA was $60.2 million, a 4.2% increase from $57.7 million in Q2 2024, representing 21.4% of revenue [14]. - Net income increased to $21.8 million from $17.8 million in Q2 2024, attributed to higher operating income and lower net interest expense [16]. - Adjusted Net Income per Diluted Share rose to $0.38, compared to $0.36 in Q2 2024 [18]. 2025 Outlook - The company expects revenue between $1.18 billion and $1.21 billion for 2025, with Adjusted EBITDA projected between $257 million and $262 million [3][23]. - Same-store sales growth is anticipated to be between 1% and 4%, supported by approximately 40 new store openings [23]. - Net Capital Expenditures are estimated at approximately $45 million for the year [24]. CEO Succession Plan - Richard Maltsbarger will transition from CEO to Senior Advisor effective September 21, 2025, with Greg Ramier, the current President and COO, succeeding him [4][5]. - Maltsbarger has led the company since 2018, overseeing significant growth and transformation initiatives [6][8]. Shareholder Returns - The Board declared a dividend of $0.12 per common share, payable on September 15, 2025 [22]. - The company repurchased 2.3 million common shares for a total consideration of $65.5 million [7]. Operational Highlights - Pet Valu completed a multi-year distribution center network transformation, enhancing its omnichannel supply chain capabilities [3]. - The company opened 3 new stores, bringing the total to 833 across its network [7]. Cash Flow and Capital Expenditures - Free Cash Flow for Q2 2025 was $27.1 million, significantly up from $7.7 million in Q2 2024, driven by increased cash from operating activities [20]. - Net Capital Expenditures were $11.9 million in Q2 2025, a slight decrease from $12.5 million in Q2 2024 [19]. Inventory Management - Inventory at the end of Q2 2025 was $140.6 million, an increase from $124.6 million at the end of Q4 2024, supporting store network growth [21].

Group 1: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - The class period for Sarepta is from June 22, 2023, to June 24, 2025, with a lead plaintiff deadline of August 25, 2025 [2] - The lawsuit alleges that Sarepta made materially false and misleading statements regarding its gene therapy ELEVIDYS, which was intended to treat Duchenne muscular dystrophy, leading investors to believe it was safe and had a positive revenue outlook [2] - Significant safety risks associated with ELEVIDYS were not disclosed, including severe side effects that led to the halting of trials and regulatory scrutiny [2][3] - Following the announcement of a patient death related to ELEVIDYS, Sarepta's stock price fell by $27.81 (27.44%) to close at $73.54 on March 18, 2025 [3] - Subsequent disclosures of additional patient deaths and regulatory investigations resulted in further stock price declines, with a notable drop of $15.24 (42.12%) to close at $20.91 on June 15, 2025 [3] Group 2: Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) - The class period for Petco is from January 14, 2021, to June 5, 2025, with a lead plaintiff deadline of August 29, 2025 [4] - The lawsuit claims that Petco made materially false and misleading statements about its business operations, particularly regarding the sustainability of pandemic-related growth and the viability of its premium pet food business model [4][5] - Defendants allegedly overstated Petco's ability to achieve sustainable, profitable growth, with a specific reference to a share price of $95.85 on May 21, 2025 [5]

Core Viewpoint - Petco Health and Wellness Company, Inc. is facing a class action securities lawsuit due to alleged securities fraud that affected investors between January 14, 2021, and June 5, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit claims that Petco's pandemic-related growth was not sustainable and that its business model, which focuses on premium pet food, was overstated [2] - Defendants allegedly downplayed the severity of issues affecting Petco's business and the necessary changes to address these issues, leading to an overstatement of the company's ability to achieve sustainable growth [2] - Public statements made by the defendants were claimed to be materially false and misleading throughout the relevant period [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until August 29, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing significant settlements for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]

Core Viewpoint - Chewy (CHWY) stock experienced a significant decline of over 20% after reaching a two-year high of $48.62 on June 6, primarily due to an 11% drop following earnings on June 11, but is currently testing a historically bullish trendline [1] Group 1: Stock Performance - CHWY is trading within one standard deviation of its 80-day moving average, having closed above this trendline in eight of the last ten sessions [2] - Historical data indicates that similar signals have led to a 78% chance of CHWY being higher one month later, with an average gain of 10.9% [3] - From its current price of $38.68, a similar gain would eliminate its 9.3% quarter-to-date deficit and extend its 15.4% year-to-date lead [3] Group 2: Technical Indicators - CHWY's 14-Day Relative Strength Index (RSI) is around 33, indicating it is in "oversold" territory, which has historically preceded rallies [3] - The stock is experiencing a potential short squeeze, with short interest up 7.7% and 15.51 million shares sold short, accounting for 7.3% of the total float [5] Group 3: Options Market Sentiment - The 10-day put/call volume ratio for CHWY is 0.68, indicating a higher level of pessimism among options traders compared to the past year [6] - Options are currently affordably priced, with a Schaeffer's Volatility Index (SVI) of 38% in the low 7th percentile of its annual range, suggesting a potential premium-selling strategy [7]

Core Viewpoint - Pet Valu Holdings Ltd. is set to release its financial results for the second quarter of fiscal 2025 on August 5, 2025, at 6:30am ET, followed by a conference call at 8:30am ET [1] Company Overview - Pet Valu is the leading Canadian specialty retailer of pet food and pet-related supplies, operating over 800 corporate-owned or franchised locations across Canada [4] - The company has been in operation for over 45 years, building trust and loyalty among pet parents through knowledgeable customer service and a wide range of products [4] - Pet Valu offers more than 10,000 competitively-priced products, including exclusive, holistic, and award-winning proprietary brands [4] - The company is headquartered in Markham, Ontario, with distribution centers located in Brampton, Ontario, Surrey, British Columbia, and Calgary, Alberta [4] - Pet Valu's shares are traded on the Toronto Stock Exchange under the ticker symbol PET [4]

Core Viewpoint - A class action lawsuit has been filed against Petco Health and Wellness Company, Inc. for alleged violations of federal securities laws during the Class Period from January 14, 2021, to June 5, 2025, claiming damages for misleading statements regarding the company's business and financial performance [1][7]. Company Overview - Petco is a specialty retailer offering a variety of pet products and services, including consumable and non-consumable products, in-store veterinary, and grooming services [3]. - The company emphasizes comparable sales as a key business metric, measuring period-over-period net sales changes from physical and digital locations [3]. Financial Performance and Misrepresentation - Petco claimed to benefit from pandemic-related tailwinds, citing increased pet adoption rates and a transformation into a health-focused pet company, capitalizing on trends of "pet humanization" and "premiumization" [4]. - However, as these pandemic-related benefits waned, Petco's sales and profitability began to decline significantly, with notable financial performance deterioration starting in mid-2023 [5]. - Despite worsening financial conditions, Petco's management continued to assert the viability of its business model centered on premium pet products, issuing optimistic financial guidance for FY 2023 [6]. Class Action Allegations - The lawsuit alleges that Petco's executives made materially false and misleading statements about the sustainability of its business model and the strength of its product strategy, downplaying the severity of issues affecting the company [7]. - Specific allegations include the unsustainability of pandemic-related growth, overstated product strategy strength, and failure to disclose the true scope of financial challenges [7]. Stock Price Impact - Following a negative revision of FY 2023 financial guidance on August 24, 2023, Petco's stock price fell by $1.35 per share, or 20.64%, closing at $5.19 [9]. - A further revision on November 29, 2023, led to a stock price drop of $1.11 per share, or 28.91%, closing at $2.73 [11]. - After disclosing a GAAP net loss of $1.3 billion and acknowledging the unsustainability of its premium product focus on March 12, 2024, Petco's stock fell by $0.50 per share, or 19.53%, to $2.06 [12][13]. Recent Developments - On June 5, 2025, Petco reported a 1.3% year-over-year decline in comparable sales, which was worse than Wall Street's expectations, resulting in a stock price drop of $0.84 per share, or 23.2%, to $2.78 [16][17].

Core Viewpoint - A class action lawsuit has been filed against Petco Health and Wellness Company, Inc. and certain officers for alleged violations of federal securities laws during the Class Period from January 14, 2021, to June 5, 2025, seeking damages for misleading statements regarding the company's business and financial performance [1][8]. Company Overview - Petco is a specialty retailer offering a variety of pet products and services, including consumable and non-consumable products, as well as in-store veterinary and grooming services [4]. - A key business metric for Petco is comparable sales, which measures the change in period-over-period net sales from physical locations and digital sites [4]. Financial Performance and Misrepresentation - Petco claimed to benefit from pandemic-related tailwinds, including increased pet adoption rates, and positioned itself as a health-focused pet company capitalizing on trends of "pet humanization" and "premiumization" [5]. - However, as these pandemic-related tailwinds diminished, Petco's sales and profitability metrics began to decline significantly, with a notable downturn in mid-2023 [6]. - Despite worsening financial conditions, Petco's management continued to affirm optimistic financial guidance for FY 2023, including adjusted EBITDA of $520 million to $540 million and adjusted EPS of $0.40 to $0.48 [7]. Class Action Allegations - The complaint alleges that Petco's management made materially false and misleading statements about the sustainability of its business model and the strength of its product strategy, which were overstated [8]. - Specific allegations include the unsustainability of pandemic-related tailwinds, downplaying the severity of issues affecting sales, and overstating the company's ability to deliver sustainable growth [8]. Recent Financial Disclosures - On August 24, 2023, Petco revised its FY 2023 adjusted EBITDA guidance down to $460 million to $480 million and adjusted EPS to $0.24 to $0.30, leading to a 20.64% drop in stock price [9][10]. - Further negative revisions were made on November 29, 2023, with adjusted EBITDA guidance lowered to approximately $400 million and adjusted EPS to approximately $0.08, resulting in a 28.91% decline in stock price [11][12]. - In March 2024, Petco reported a GAAP net loss of $1.3 billion and acknowledged that its premium product-focused business model was not sustainable [13]. Market Reaction - Following the negative financial disclosures, Petco's stock price experienced significant declines, including a drop to $2.06 per share after the March 2024 results [14]. - On June 5, 2025, Petco reported a 1.3% year-over-year decline in comparable sales, larger than Wall Street estimates, leading to a further 23.2% drop in stock price [17][18].